Malaysia · Delayed Price · Currency is MYR Genting Malaysia Berhad Statistics
Total Valuation
KLSE:GENM has a market cap or net worth of MYR 8.44 billion. The enterprise value is 21.68 billion.
| Market Cap | 8.44B |
| Enterprise Value | 21.68B |
Important Dates
The next estimated earnings date is Wednesday, November 25, 2026.
| Earnings Date | Nov 25, 2026 |
| Ex-Dividend Date | Mar 13, 2026 |
Share Statistics
KLSE:GENM has 5.67 billion shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | 5.67B |
| Shares Outstanding | 5.67B |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.94% |
| Owned by Institutions (%) | 4.98% |
| Float | 1.43B |
Valuation Ratios
The trailing PE ratio is 27.32 and the forward PE ratio is 17.07. KLSE:GENM's PEG ratio is 3.60.
| PE Ratio | 27.32 |
| Forward PE | 17.07 |
| PS Ratio | 0.65 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 16.12 |
| P/OCF Ratio | 3.99 |
| PEG Ratio | 3.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.62, with an EV/FCF ratio of 41.39.
| EV / Earnings | 70.15 |
| EV / Sales | 1.66 |
| EV / EBITDA | 8.62 |
| EV / EBIT | 19.30 |
| EV / FCF | 41.39 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.74.
| Current Ratio | 0.80 |
| Quick Ratio | 0.73 |
| Debt / Equity | 1.74 |
| Debt / EBITDA | 7.12 |
| Debt / FCF | 34.33 |
| Interest Coverage | 1.44 |
Financial Efficiency
Return on equity (ROE) is 2.09% and return on invested capital (ROIC) is 2.19%.
| Return on Equity (ROE) | 2.09% |
| Return on Assets (ROA) | 2.23% |
| Return on Invested Capital (ROIC) | 2.19% |
| Return on Capital Employed (ROCE) | 4.19% |
| Weighted Average Cost of Capital (WACC) | 3.59% |
| Revenue Per Employee | 730,025 |
| Profits Per Employee | 17,237 |
| Employee Count | 17,932 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 46.60 |
Taxes
In the past 12 months, KLSE:GENM has paid 262.20 million in taxes.
| Income Tax | 262.20M |
| Effective Tax Rate | 54.11% |
Stock Price Statistics
The stock price has decreased by -31.34% in the last 52 weeks. The beta is 0.49, so KLSE:GENM's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -31.34% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 23.88 |
| Average Volume (20 Days) | 2,744,740 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:GENM had revenue of MYR 13.09 billion and earned 309.10 million in profits. Earnings per share was 0.05.
| Revenue | 13.09B |
| Gross Profit | 3.59B |
| Operating Income | 1.13B |
| Pretax Income | 484.60M |
| Net Income | 309.10M |
| EBITDA | 2.41B |
| EBIT | 1.13B |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 3.82 billion in cash and 17.99 billion in debt, with a net cash position of -14.17 billion or -2.50 per share.
| Cash & Cash Equivalents | 3.82B |
| Total Debt | 17.99B |
| Net Cash | -14.17B |
| Net Cash Per Share | -2.50 |
| Equity (Book Value) | 10.34B |
| Book Value Per Share | 1.99 |
| Working Capital | -1.25B |
Cash Flow
In the last 12 months, operating cash flow was 2.12 billion and capital expenditures -1.59 billion, giving a free cash flow of 523.90 million.
| Operating Cash Flow | 2.12B |
| Capital Expenditures | -1.59B |
| Depreciation & Amortization | 1.28B |
| Net Borrowing | 2.72B |
| Free Cash Flow | 523.90M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 27.41%, with operating and profit margins of 8.65% and 2.36%.
| Gross Margin | 27.41% |
| Operating Margin | 8.65% |
| Pretax Margin | 3.70% |
| Profit Margin | 2.36% |
| EBITDA Margin | 18.41% |
| EBIT Margin | 8.65% |
| FCF Margin | 4.00% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 4.70%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 4.70% |
| Dividend Growth (YoY) | -30.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 128.34% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.03% |
| Shareholder Yield | 4.72% |
| Earnings Yield | 3.66% |
| FCF Yield | 6.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KLSE:GENM is 2.21, which is 48.32% higher than the current price. The consensus rating is "Buy".
| Price Target | 2.21 |
| Price Target Difference | 48.32% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 10.49% |
| EPS Growth Forecast (3Y) | -2.79% |
Stock Splits
The last stock split was on April 11, 2007. It was a forward split with a ratio of 5.
| Last Split Date | Apr 11, 2007 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KLSE:GENM has an Altman Z-Score of 1.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.16 |
| Piotroski F-Score | 6 |